Not available
Quote | Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)
Last: | $903.48 |
---|---|
Change Percent: | 0.14% |
Open: | $889.41 |
Close: | $903.48 |
High: | $913.21 |
Low: | $888.52 |
Volume: | 594,888 |
Last Trade Date Time: | 05/01/2024 03:00:00 am |
News | Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)
2024-05-01 13:18:37 ET More on Adverum Biotechnologies Seeking Alpha’s Quant Rating on Adverum Biotechnologies Historical earnings data for Adverum Biotechnologies Financial information for Adverum Biotechnologies Read the full article on Seeking Alp...
2024-05-01 11:30:13 ET More on Regeneron Pharmaceuticals Regeneron's Triple Threat: Eylea, Libtayo, And Dupixent Dominate Regeneron Pharmaceuticals, Inc. (REGN) Leerink Partners Global Biopharma Conference (Transcript) Regeneron Pharmaceuticals, Inc. (REGN) Barclays ...
Message Board Posts | Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $REGN News Article - Wall Street Has High Hopes for These 2 Nasdaq Stocks | whytestocks | investorshangout | 03/24/2023 4:45:46 PM |
whytestocks: $REGN News Article - Why Shares of Regeneron Are Rising Thursday | whytestocks | investorshangout | 03/23/2023 4:15:52 PM |
whytestocks: $REGN News Article - Dupixent (dupilumab) Demonstrates Potential to Become First Biolog | whytestocks | investorshangout | 03/23/2023 2:05:57 PM |
$REGN clearly states in their filing that the | zj3001 | investorshub | 03/21/2023 1:55:21 PM |
anyone on this board know anything about regn | 1jas | investorshub | 03/19/2023 7:00:28 PM |
News, Short Squeeze, Breakout and More Instantly...
Regeneron Pharmaceuticals Inc. Company Name:
REGN Stock Symbol:
NASDAQ Market:
Regeneron Pharmaceuticals Inc. Website:
TARRYTOWN, N.Y., April 29, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the presentation of positive long-term results and subgroup analyses from the pivotal clinical program of EYLEA ® HD (aflibercept) Injection 8 mg. The presentations are part...
2024-04-28 20:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Thursday, AbbVie Inc (NASDAQ:ABBV) released topline results from LEVEL UP, an open-label, efficacy assessor-blinded head-to-head Pha...